Quest Diagnostics (DGX) Short Interest Ratio & Short Volume → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free DGX Stock Alerts $137.55 +0.85 (+0.62%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Quest Diagnostics Short Interest DataCurrent Short Volume2,550,000 sharesPrevious Short Volume2,650,000 sharesChange Vs. Previous Month-3.77%Dollar Volume Sold Short$339.43 millionShort Interest Ratio / Days to Cover2.4Last Record DateMarch 31, 2024Outstanding Shares111,060,000 sharesFloat Size109,710,000 sharesShort Percent of Float2.32%Today's Trading Volume1,566,421 sharesAverage Trading Volume1,064,314 sharesToday's Volume Vs. Average147% Short Selling Quest Diagnostics ? Sign up to receive the latest short interest report for Quest Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDGX Short Interest Over TimeDGX Days to Cover Over TimeDGX Percentage of Float Shorted Over Time Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> Quest Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20242,550,000 shares $339.43 million -3.8%2.3%2.4 $133.11 3/15/20242,650,000 shares $339.94 million -3.6%2.4%2.6 $128.28 2/29/20242,750,000 shares $343.45 million -7.4%2.5%2.6 $124.89 2/15/20242,970,000 shares $373.42 million -13.7%2.7%2.9 $125.73 1/31/20243,440,000 shares $441.76 million +13.2%3.1%3.5 $128.42 1/15/20243,040,000 shares $411.31 million +22.1%2.7%3.1 $135.30 Get the Latest News and Ratings for DGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,490,000 shares $343.32 million -2.4%2.2%2.7 $137.88 12/15/20232,550,000 shares $344.33 million +12.3%2.3%2.7 $135.03 11/30/20232,270,000 shares $311.51 million -15.6%2.0%2.5 $137.23 11/15/20232,690,000 shares $364.41 million +7.2%2.4%3 $135.47 10/31/20232,510,000 shares $326.55 million -15.5%2.3%2.9 $130.10 10/15/20232,970,000 shares $363.83 million +2.1%2.7%3.6 $122.50 9/30/20232,910,000 shares $354.61 million +3.9%2.6%3.8 $121.86 9/15/20232,800,000 shares $353.42 million -4.8%2.5%3.6 $126.22 8/31/20232,940,000 shares $386.61 million -9.5%2.6%3.6 $131.50 8/15/20233,250,000 shares $434.01 million +0.6%2.9%3.7 $133.54 7/31/20233,230,000 shares $436.73 million +6.6%2.9%3.6 $135.21 7/15/20233,030,000 shares $425.53 million -10.1%2.7%3.2 $140.44 6/30/20233,370,000 shares $473.69 million -10.4%3.0%3.5 $140.56 6/15/20233,760,000 shares $515.65 million -7.2%3.4%3.8 $137.14 5/31/20234,050,000 shares $537.27 million -0.7%3.7%3.8 $132.66 5/15/20234,080,000 shares $540.19 million -4.0%3.7%3.7 $132.40 4/30/20234,250,000 shares $589.94 million +3.2%3.8%3.7 $138.81 4/15/20234,120,000 shares $586.44 million +15.1%3.7%3.6 $142.34 3/31/20233,580,000 shares $506.50 million +19.3%3.2%3 $141.48 3/15/20233,000,000 shares $398.55 million -9.6%2.7%2.5 $132.85 2/28/20233,320,000 shares $459.36 million +8.9%3.0%2.9 $138.36 2/15/20233,050,000 shares $447.19 million +11.3%2.8%2.9 $146.62 1/31/20232,740,000 shares $406.84 million -17.0%2.4%2.4 $148.48 1/15/20233,300,000 shares $488.20 million -12.5%2.9%2.9 $147.94 12/30/20223,770,000 shares $589.78 million -5.8%3.3%3.4 $156.44 12/15/20224,000,000 shares $596.88 million -12.3%3.5%3.6 $149.22 11/30/20224,560,000 shares $692.34 million -13.8%4.0%4.2 $151.83 11/15/20225,290,000 shares $782.60 million +5.6%4.7%5.1 $147.94 10/31/20225,010,000 shares $719.69 million +2.5%4.4%5.1 $143.65 10/15/20224,890,000 shares $616.68 million -6.3%4.3%5.3 $126.11 9/30/20225,220,000 shares $640.44 million -5.6%4.5%6.1 $122.69 9/15/20225,530,000 shares $687.27 million +2.4%4.8%6.6 $124.28 8/31/20225,400,000 shares $676.67 million +10.4%4.7%6.4 $125.31 8/15/20224,890,000 shares $689.98 million +2.1%4.2%5.6 $141.10Pentagon contract could send this $2 AI stock soaring (Ad)Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> DGX Short Interest - Frequently Asked Questions What is Quest Diagnostics' current short interest? Short interest is the volume of Quest Diagnostics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 2,550,000 shares of DGX short. 2.32% of Quest Diagnostics' shares are currently sold short. Learn More on Quest Diagnostics' current short interest. What is a good short interest ratio for Quest Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DGX shares currently have a short interest ratio of 2.0. Learn More on Quest Diagnostics's short interest ratio. Which institutional investors are shorting Quest Diagnostics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Quest Diagnostics: PEAK6 Investments LLC, Capstone Investment Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Quest Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.32% of Quest Diagnostics' floating shares are currently sold short. Is Quest Diagnostics' short interest increasing or decreasing? Quest Diagnostics saw a decrease in short interest in March. As of March 31st, there was short interest totaling 2,550,000 shares, a decrease of 3.8% from the previous total of 2,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Quest Diagnostics' float size? Quest Diagnostics currently has issued a total of 111,060,000 shares. Some of Quest Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Quest Diagnostics currently has a public float of 109,710,000 shares. How does Quest Diagnostics' short interest compare to its competitors? 2.32% of Quest Diagnostics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Quest Diagnostics: Teva Pharmaceutical Industries Limited (1.03%), Viatris Inc. (3.14%), Neurocrine Biosciences, Inc. (2.44%), BeiGene, Ltd. (1.81%), BioMarin Pharmaceutical Inc. (1.62%), Avantor, Inc. (4.32%), Laboratory Co. of America Holdings (2.29%), Revvity, Inc. (2.19%), Medpace Holdings, Inc. (3.82%), Fresenius Medical Care AG (0.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Quest Diagnostics stock? Short selling DGX is an investing strategy that aims to generate trading profit from Quest Diagnostics as its price is falling. DGX shares are trading down $0.32 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Quest Diagnostics? A short squeeze for Quest Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DGX, which in turn drives the price of the stock up even further. How often is Quest Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DGX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Teva Pharmaceutical Industries Short Interest Viatris Short Interest Neurocrine Biosciences Short Interest BeiGene Short Interest BioMarin Pharmaceutical Short Interest Avantor Short Interest Laboratory Co. of America Short Interest Revvity Short Interest Medpace Short Interest Fresenius Medical Care Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:DGX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals